Consistent with this idea, similarly to CIC, SLC13A5 is upregulated in diet-induced NAFLD/NASH and its inhibition prevents some of the pathological hallmarks of this disease [28]. This evidence concerns the gene SLC13A5 and metabolic dysfunction-associated steatotic liver disease.